partner with:

Reinventing a bacterial biopesticide: an old microbe with a fresh new look

Growing concerns over the use of synthetic pesticides in agriculture have sparked a renewed interest in natural alternatives. Our work revisits a formerly successful bacterial biological pesticide (biopesticide) that fell out of fashion over concerns of human pathogenicity.

Credits: Pixabay - CC0
by Alex J. Mullins | PhD student

Alex J. Mullins is PhD student at Microbiomes, Microbes and Informatics Group, Organisms and Environment Division, School of Biosciences, Cardiff University, Cardiff, UK.

Alex J. Mullins is also an author of the original article

Edited by

Massimo Caine

Founder and Director

Views 3851
Reading time 3.5 min
published on Sep 24, 2019

In the 1980s it was discovered that some relatives of the bacterium Burkholderia cepacia (formerly Pseudomonas cepacia) were able to form close relationships with plant roots, and also make a range of antimicrobials capable of killing plant pathogens. Several US pesticide companies exploited this bacterium in biological pesticide (biopesticide) products in the 1990s. Coating crop seeds with this soil bacterium offered protection against plant pathogens that would otherwise kill up to 60% of crops. These seed coat bacterial biopesticides offered a non-toxic alternative to man-made chemical pesticides.

Around the same time B. cepacia bacteria were also found to cause infections in immunocompromised individuals, such as people with cystic fibrosis. The presence of B. cepacia in the lungs of cystic fibrosis patients was associated with poor clinical outcomes. Concerns over the use of B. cepacia in agriculture and the potential for human infections prompted the US Environmental Protection Agency to hold a scientific advisory meeting to discuss these bacteria. The outcome of this meeting was a suspension on registering new biopesticides containing B. cepacia until they could be proven safe.

B. cepacia-based biopesticide products registered before the scientific advisory meeting could still be used in agriculture, but these eventually fell out of favour alongside a rise in the use of synthetic pesticides. Over the next 20 years our understanding of B. cepacia increased dramatically. Researchers recognised that B. cepacia actually represented at least 20 different species, each one possessing a different pathogenicity risk in humans, but all capable of causing infections in vulnerable people. The bacterium used as a biopesticide was named B. ambifaria and was rarely encountered in human infections; while the species most problematic in cystic fibrosis infections were B. multivorans and B. cenocepacia. Growing concerns over the use of synthetic pesticides on agriculture, combined with a better understanding of these bacteria prompted us to re-visit B. ambifaria as an alternative to synthetic pesticides.

This study began by sequencing the genomes of multiple B. ambifaria strains to understand the genetic diversity of the bacterium. We used computer software designed to analyse bacterial DNA sequences to identify genes involved in antimicrobial production. This informed us of the widespread nature of antimicrobial synthesis in B. ambifaria - every strain possessed genes to produce antimicrobials. Our second goal was to screen all the strains for pathogen-killing activity and understand which genes were involved in antimicrobial production. We chose a wide range of plant pathogens: bacterial, fungal, and fungal-like organisms (oomycetes) - these pathogens cause diseases such as leaf wilt, leaf blight and damping-off. Interestingly, we found correlations between the presence of different antimicrobial production genes and the killing of different pathogens.

Some of these antimicrobial production genes identified were new and as yet uncharacterised, so we disrupted their activity to see their effect on plant pathogen killing. These genes were responsible for killing the oomycete plant pathogen Pythium when tested in laboratory conditions. The newly characterised genes were found to make an old antibiotic called cepacin. To test their role in a biopesticide model we coated pea seeds in B. ambifaria with either functioning or non-functioning (mutated) cepacin genes, and challenged the seeds with the plant pathogen Pythium. Seeds coated with the cepacin-producing B. ambifaria survived, while the B. ambifaria with mutated cepacin genes did not protect the germinating seeds.

The genomes of B. ambifaria are interesting as their DNA is spread across three chromosomes, the smallest of which can be deleted and yet the bacteria remain viable. A favourable consequence of this chromosome deletion is reduced virulence in multiple infection models. We repeated this for our B. ambifaria strain and deleted the smallest chromosome (knockout B. ambifaria) and then asked two questions: did the bacteria still protect seeds from pathogens due to the cepacin-making genes? And was the small chromosome knockout B. ambifaria less virulent? We were excited that the knockout B. ambifaria performed as well as the normal B. ambifaria in protecting pea seeds from Pythium, but was more easily cleared from the lungs of a mouse model compared to the normal B. ambifaria.

In summary, we identified the genes responsible for making cepacin - a key biopesticide activity in the bacterium B. ambifaria; and even though the normal B. ambifaria had low virulence, we were able to further reduce its infectious ability by deleting a part of the genome. This paves the way for using B. ambifaria as a substitute to synthetic pesticides in protecting crops from plant pathogens, while addressing concerns over pathogenicity.

Edited by:

Massimo Caine , Founder and Director

We thought you might like